Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

HOFFMANN-LA ROCHE INC.;PATENT LAW DEPARTMENT

NUTLEY, NJ US

1. 20100063101 NEW BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel benzimidazole derivatives of formula STR00001 wherein A, n and R 03-11-2010
2. 20100063042 5-SUBSTITUTED BENZOXAZINES - The present invention is concerned with 5-substituted benzoxazine derivatives of formula STR00001 wherein X, R 03-11-2010
3. 20100063037 6-SUBSTITUTED BENZOXAZINES - The present invention is concerned with 6-substituted benzoxazine derivatives of formula STR00001 wherein X, Y, R 03-11-2010
4. 20100056513 STEREOSPECIFICALLY SUBSTITUTED BENZO[1,3]DIOXOLYL DERIVATIVES 03-04-2010
5. 20100048569 DIAZOLE DERIVATIVES - of the general formula STR00001 wherein A, E, R 02-25-2010
6. 20100048531 GlyT1 RECEPTOR ANTAGONISTS - compound of formula I STR00001 wherein R 02-25-2010
7. 20100041886 ISOXAZOLO-PYRAZINE DERIVATIVES - and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A 02-18-2010
8. 20100041760 MONOARYL AMINOTETRALINES - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters 02-18-2010
9. 20100041714 BI-ARYL AMINOTETRALINES - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters thereof, 02-18-2010
10. 20100041713 SUBSTITUTED AMINOTETRALINES - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and esters 02-18-2010
11. 20100041686 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - compounds of formula I STR00001 wherein R 02-18-2010
12. 20100041684 PYRIMIDYL DERIVATIVES AS PROTEIN KINASE INHIBITORS 02-18-2010
13. 20100041063 ANTI-DRUG ANTIBODY ASSAY - antibody binding specifically to Cynomolgus IgG characterized by not binding to Human IgG 02-18-2010
14. 20100035953 Pyrazole Phenyl Derivatives - compounds of the formula I: STR00001 wherein one of R 02-11-2010
15. 20100035817 METHOD FOR THE PRODUCTION OF CONJUGATES OF INSULIN-LIKE GROWTH FACTOR-1 AND POLY(ETHYLENE GLYCOL) 02-11-2010
16. 20100029664 PYRROLIDIN-3-YLMETHYL-AMINE AS OREXIN ANTAGONISTS 02-04-2010
17. 20100029589 4,5-DIHYDRO-OXAZOL-2YL DERIVATIVES - compounds of formula I STR00001 whereinR 02-04-2010
18. 20100028949 SHRNA-MEDIATED INHIBITION OF EXPRESSION OF ALPHA 1,6-FUCOSYLTRANSFERASE 02-04-2010
19. 20100022518 NOVEL HETEROCYCLYL COMPOUNDS - The invention is concerned with novel heterocyclyl compounds of formula : STR00001 wherein A, X, R 01-28-2010
20. 20100021965 Protein Expression in Rodent Cells - method is described for the expression of heterologous polypeptides in rodent cells 01-28-2010
21. 20100016369 AMINOTETRAHYDROINDAZOLOACETIC ACIDS - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and 01-21-2010
22. 20100016368 AMINOTETRAHYDROINDAZOLOACETIC ACIDS - The invention is concerned with the compounds of formula I: STR00001 and pharmaceutically acceptable salts and 01-21-2010
23. 20100016325 TETRAHYDROCINNOLINE DERIVATIVES - Provided herein are compounds of formula : STR00001 as well as pharmaceutically acceptable salts and esters thereof 01-21-2010
24. 20100016282 NOVEL HETEROCYCLYL COMPOUNDS - The invention is concerned with novel heterocyclyl compounds of formula STR00001 wherein A, X, Y 01-21-2010
25. 20100015627 SELECTION METHOD - The current invention comprises a method for the selection of a mammalian cell by transfecting a mammalian cell with a nucleic acid 01-21-2010
26. 20100009462 Timp-2 as target/marker of beta cell failure 01-14-2010
27. 20100004297 NOVEL HEXAFLUOROISOPROPANOL DERIVATIVES - The invention is concerned with novel hexafluoroisopropanol derivatives of formula STR00001 wherein R 01-07-2010
28. 20090326253 NOVEL PHOSPHINE LIGANDS - The invention is concerned with new phosphine ligands of the formula I STR00001 wherein R 12-31-2009
29. 20090318474 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR 2 ANTAGONISTS 12-24-2009
30. 20090318467 NOVEL HETEROARYL CARBOXAMIDE DERIVATIVES 12-24-2009
31. 20090318428 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS 12-24-2009
32. 20090318408 HALO-SUBSTITUTED PYRIMIDODIAZEPINES - PLK1 inhibitor compounds of formula I: STR00001 useful in the treatment or control of cell proliferative disorders 12-24-2009
33. 20090312569 NOVEL PROCESS - process for the preparation of 1--cyclohexanecarboxylic acid which is useful as an intermediate in the preparation of pharmaceutically 12-17-2009
34. 20090312382 NOVEL IMIDAZOLIDINE DERIVATIVES - The invention is concerned with novel imidazolidine derivatives of formula STR00001 wherein R 12-17-2009
35. 20090312327 PYRROLIDINE DERIVATIVES AS NK2 RECEPTOR ANTAGONISTS 12-17-2009
36. 20090312314 HETEROAROMATIC MONOAMIDES AS OREXININ RECEPTOR ANTAGONISTS 12-17-2009
37. 20090312289 IBANDRONATE POLYMORPH - new crystalline polymorph of 3-amino-1-hydroxypropane-1 1-diphosphonic acid monosodium salt monohydrate with the following 12-17-2009
38. 20090311779 ANTI-P-SELECTIN ANTIBODIES - This invention relates to anti-P-selectin antibodies and in particular to anti-P-selectin antibodies and variants thereof 12-17-2009
39. 20090311725 POLYPEPTIDE PRODUCING CELLS - The current invention describes a nucleic acid comprising in a 5' to 3' direction 12-17-2009
40. 20090306423 PROCESS FOR THE PREPARATION OF HALOGENATED BENZOIC ACID DERIVATIVES 12-10-2009
41. 20090306043 PYRROLIDINE ETHER DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 12-10-2009
42. 20090304795 TABLETS WITH IMPROVED DRUG SUBSTANCE DISPERSIBILITY 12-10-2009
43. 20090291968 SUBSTITUTED INDAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 11-26-2009
44. 20090286848 NOVEL N-(2-AMINO-PHENYL)-ACRYLAMIDES - the compounds of formula STR00001 wherein R 11-19-2009
45. 20090286812 GPR119 Receptor Agonists - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 11-19-2009
46. 20090286235 Mdr1 Snp in Acute Rejection - The present invention concerns a method for the prediction of acute renal transplant rejection by detecting a polymorphism 11-19-2009
47. 20090286234 IL10 SNP ASSOCIATED WITH ACUTE REJECTION 11-19-2009
48. 20090275573 Imidazolidinone Derivatives as 11B-HSD1 Inhibitors 11-05-2009
49. 20090275126 ANTIBODIES AGAINST INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND USES THEREOF 11-05-2009
50. 20090270506 CRYSTALLINE STRUCTURE OF OXIDOSQUALENE SYNTHASE 10-29-2009
51. 20090270505 4-DIMETHYLAMINOBUTYRIC ACID DERIVATIVES - This invention relates to novel 4-dimethylaminobutyric acid derivatives of the formula STR00001 wherein A 10-29-2009
52. 20090270500 4-TRIMETHYLAMMONIO-BUTYRATES AS CPT2 INHIBITORS 10-29-2009
53. 20090270360 DICARBOXAMIDE DERIVATIVES - The invention is concerned with novel dicarboxamide derivatives of formula STR00001 wherein A, B, R 10-29-2009
54. 20090264485 Pyrazole Derivatives, Their Manufacture and Their Use as Pharmaceutical Agents 10-22-2009
55. 20090264445 PYRROLIDINONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 10-22-2009
56. 20090264434 PYRIDAZINONE GLUCOKINASE ACTIVATORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 10-22-2009
57. 20090264418 5-AMIDO-INDOLE-2-CARBOXAMIDE DERIVATIVES 10-22-2009
58. 20090253928 PREPARATION FOR A CYCLOHEXANECARBOXYLIC ACID DERIVATIVE AND INTERMEDIATES 10-08-2009
59. 20090253927 PROCESS FOR CYCLOHEXANECARBOXYLIC ACID DERIVATIVES 10-08-2009
60. 20090253698 Brain, Spinal and Nerve Injury Treatment 10-08-2009
61. 20090253684 LEUKOTRIENE B4 INHIBITORS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 10-08-2009
62. 20090253628 Use of PEGylated IGF-I variants for the treatment of neuromuscular disorders 10-08-2009
63. 20090253150 Three Part Assay for Kinase or Phosphatase Activity 10-08-2009
64. 20090247637 Novel Anthranilic Acid Derivatives - The invention is concerned with novel anthranilic acid derivatives of formula STR00001 wherein R 10-01-2009
65. 20090247588 2-TRIFLUOROMETHYLNICOTINAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS 10-01-2009
66. 20090247550 3-TRIFLUOROMETHYL-PYRAZINE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS 10-01-2009
67. 20090247518 6-(2-ALKYL-PHENYL)-PYRIDO[2,3-D]PYRIMIDINES USEFUL AS PROTEIN KINASE INHIBITORS 10-01-2009
68. 20090246197 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) 10-01-2009
69. 20090240080 PROCESS FOR THE PREPARATION OF CETP(1) - process for the preparation of 1--cyclohexanecarboxylic acid which is useful as an intermediate in the 09-24-2009
70. 20090239889 Spiroindolinone Derivatives - There are provided compounds of the general formulas STR00001 wherein W, X, Y, R 09-24-2009
71. 20090232811 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 09-17-2009
72. 20090221599 PHTHALAZINONE PYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 09-03-2009
73. 20090215826 SOLID FORMS OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE 08-27-2009
74. 20090215759 MODULATORS FOR AMYLOID BETA - compounds of formula STR00001 wherein the substituents are as described in claim 1 08-27-2009
75. 20090215069 Pancreatic polypeptide as target/marker of beta cell failure 08-27-2009
76. 20090209529 4,5-DIHYDRO-OXAZOL-2-YL AMINE DERIVATIVES 08-20-2009
77. 20090208971 Insulin promoter factor 1 as target/marker of beta cell failure 08-20-2009
78. 20090203736 PIPERIDINE SULPHONAMIDE DERIVATIVES - of formula STR00001 wherein Ar 08-13-2009
79. 20090203681 NOVEL N-(2-AMINO-PHENYL)-AMIDE DERIVATIVES 08-13-2009
80. 20090203665 HETEROCYCLIC-SUBSTITUTED PHENYL METHANONES 08-13-2009
81. 20090197875 ARYL-ISOXAZOLO-4-YL-OXADIAZOLE DERIVATIVES 08-06-2009
82. 20090192333 PROCESS FOR THE PREPARATION OF ACID HALIDES 07-30-2009
83. 20090192136 BENZOYL-PIPERAZINE DERIVATIVES - compound of formula STR00001 wherein the substituents are as described in the specification for the treatment of 07-30-2009
84. 20090191187 ANTIBODIES AGAINST INTERLEUKIN-1 RECEPTOR AND USES THEREOF 07-30-2009
85. 20090186920 SULFONAMIDES AS OREXIN ANTAGONISTS - The present invention is concerned with novel sulfonamides of formula STR00001 wherein R 07-23-2009
86. 20090181965 MODULATORS FOR AMYLOID BETA - compounds of formula STR00001 wherein R 07-16-2009
87. 20090181944 METHOD FOR CANCER THERAPY - method for treating a patient having cancer comprising administering to the patient a therapeutically effective amount of 07-16-2009
88. 20090175851 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 07-09-2009
89. 20090171100 METHOD FOR PREPARING ENANTIOMERICALLY PURE 4-PYRROLIDINO PHENYLBENZYL ETHER DERIVATIVES 07-02-2009
90. 20090170920 SUBSTITUTED HYDANTOINS - compounds of the formula STR00001 methods for the preparation thereof, and methods for their use 07-02-2009
91. 20090170864 Diacylglycerol Acyltransferase Inhibitors 07-02-2009
92. 20090163552 CARBOXYL- OR HYDROXYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES 06-25-2009
93. 20090163546 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS 06-25-2009
94. 20090163517 BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES 06-25-2009
95. 20090163512 Spiroindolinone Derivatives - There are provided compounds of the formula STR00001 and pharmaceutically acceptable salts and esters and enantiomers 06-25-2009
96. 20090163485 HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 06-25-2009
97. 20090162360 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 06-25-2009
98. 20090162359 BIVALENT, BISPECIFIC ANTIBODIES - novel domain exchanged, bivalent, bispecific antibodies, their manufacture and use 06-25-2009
99. 20090162352 ANTIBODY FORMULATION - pharmaceutical formulation comprising an anti-CD20 antibody 06-25-2009
100. 20090156635 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS 06-18-2009
101. 20090156610 Spiroindolinone Derivatives - There are provided compounds of the formula STR00001 and pharmaceutically acceptable salts and esters thereof wherein W 06-18-2009
102. 20090156583 Tricyclic Amide Derivatives - compounds of formula I STR00001 wherein A, G, r and R 06-18-2009
103. 20090155356 THIXOTROPIC OIL BASED VEHICLE FOR PHARMACEUTICAL COMPOSITIONS 06-18-2009
104. 20090149503 NEW 5-ARYL PYRIDINES AS 11-BETA INHIBITORS FOR THE TREATMENT OF DIABETES 06-11-2009
105. 20090149466 INHIBITORS OF STEAROYL-COA DESATURASE - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 06-11-2009
106. 20090143580 SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AS METABOTROPIC GLUTAMATE ANTAGONISTS 06-04-2009
107. 20090143448 NEW AMINOTHIAZOLES AS FBPASE INHIBITORS FOR DIABETES 06-04-2009
108. 20090143439 NEW PYRIDINES AS FBPASE INHIBITORS FOR TREATMENT OF DIABETES 06-04-2009
109. 20090143409 3-PYRIDINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS 06-04-2009
110. 20090143407 ISOXAZOLO-PYRAZINE DERIVATIVES - and their pharmaceutically acceptable salts having affinity and selectivity for the GABA A 06-04-2009
111. 20090143385 ISOXAZOLO-PYRIDAZINE DERIVATIVES - isoxazolo-pyridazine compounds in particular those of formula I as described above and to a pharmaceutically 06-04-2009
112. 20090143375 Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents 06-04-2009
113. 20090143371 ISOXAZOLE-PYRIDINE DERIVATIVES - The present invention is concerned with isoxazole-pyridine derivatives of formula I STR00001 wherein X, R 06-04-2009
114. 20090143364 CHIRAL CIS-IMIDAZOLINES - and the pharmaceutically acceptable salts and esters thereof, wherein X 06-04-2009
115. 20090137806 DUAL NK1/NK3 RECEPTOR ANTAGONISTS - method for the treatment of schizophrenia which comprises administering a compound of formula STR00001 wherein the 05-28-2009
116. 20090136939 Methods for diagnosis and therapy for pancreatic cancer and composition useful therein 05-28-2009
117. 20090131482 METHYL-BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel substituted benzimidazole derivatives of formula STR00001 wherein R 05-21-2009
118. 20090130770 BIOMARKER FOR FARNESYL PATHWAY - novel biomarker which can be used to determine the extent of interference of a substance with the farnesyl pathway 05-21-2009
119. 20090130660 Single Nucelotide Polymorphism (SNP) - Association of Type 2 diabetes with single nucleotide polymorphisms and haplotypes are disclosed 05-21-2009
120. 20090123943 Characterization and Identification of Unique Human Adiponectin Isoforms and Antibodies 05-14-2009
121. 20090118546 METHODS FOR STABILIZING LITHIATED HALOGEN-SUBSTITUTED AROMATIC COMPOUNDS 05-07-2009
122. 20090118476 Purification of pegylated polypeptides - The invention is a method for the purification of mono-PEGylated erythropoietin using two cation exchange 05-07-2009
123. 20090117662 Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof 05-07-2009
124. 20090111789 CHIRAL CIS-IMIDAZOLINES - There are provided compounds of the formula STR00001 or the pharmaceutically acceptable salts thereof, wherein X, Y, Z, V 04-30-2009
125. 20090110688 COMBINATION THERAPY OF TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR 04-30-2009
126. 20090105480 PROCESS FOR THE PREPARATION OF A DPP-IV INHIBITOR 04-23-2009
127. 20090105477 Quinazoline Protein Tyrosine Phosphatase Inhibitors 04-23-2009
128. 20090105307 2-AMINOOXAZOLINES AS TAAR1 LIGANDS - compounds of formula STR00001 wherein R 04-23-2009
129. 20090105273 Diacylglycerol Acyltransferase Inhibitors 04-23-2009
130. 20090099201 Diacylglycerol Acyltransferase Inhibitors 04-16-2009
131. 20090098660 Method for the Purification of Antibodies 04-16-2009
132. 20090098118 COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT 04-16-2009
133. 20090093497 Diacylglycerol Acyltransferase Inhibitors 04-09-2009
134. 20090093491 Diazine Azole Derivatives, Their Manufacture and Use as Pharmaceutical 04-09-2009
135. 20090088459 NOVEL BIARYL SULFONAMIDE DERIVATIVES - The invention is concerned with novel biaryl sulfonamide derivatives of formula STR00001 wherein R 04-02-2009
136. 20090088451 QUINOLINES - 2-aminoquinolines of formula I STR00001 wherein R 04-02-2009
137. 20090088425 GLUCOCORTICOID RECEPTOR ANTAGONISTS - compounds of formula I STR00001 wherein A, n, R 04-02-2009
138. 20090082310 PRODRUGS OF THYROID HORMONE ANALOGS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 03-26-2009
139. 20090076275 DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS 03-19-2009
140. 20090076081 PIPERIDINE DERIVATIVES AS NK3 ANTAGONISTS 03-19-2009
141. 20090069311 5-AMINOINDOLE DERIVATIVES AS H3 INVERSE AGONISTS 03-12-2009
142. 20090062356 SUBSTITUTED BENZIMIDAZOLE DERIVATIVES - The invention is concerned with novel substituted benzimidazole derivatives of formula STR00001 wherein R 03-05-2009
143. 20090062276 PYRIDOPYRIMIDINE PROTEIN TYROSINE PHOSPHATASE INHIBITORS 03-05-2009
144. 20090061466 ANTI-DRUG ANTIBODY ASSAY - method for the immunological determination of an antibody against a drug antibody in a sample using a double antigen bridging 03-05-2009
145. 20090060913 COMBINATION THERAPY WITH TYPE I AND TYPE II ANTI-CD20 ANTIBODIES 03-05-2009
146. 20090054644 PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS 02-26-2009
147. 20090054490 METHODS FOR THE TREATMENT OF GERD WITH MGLUR5 ANTAGONISTS 02-26-2009
148. 20090054481 Saquinavir Mesylate Oral Dosage Form - solid unit oral pharmaceutical dosage form of saquinavir mesylate is provided comprising micronized saquinavir 02-26-2009
149. 20090054466 Leukotriene B4 Inhibitors - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 02-26-2009
150. 20090048452 SUBSTITUTED HYDANTOINS - This invention relates to compounds of formula I: STR00001 or pharmaceutically acceptable salts thereof 02-19-2009
151. 20090048274 PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES - Disclosed are novel pyrazolo[3,4-d]pyrimidine derivatives that are inhibitors of Raf kinase 02-19-2009
152. 20090048264 PIPERAZINE AMIDE DERIVATIVES - The invention is concerned with novel piperazine amide derivatives of formula STR00001 wherein R 02-19-2009
153. 20090048238 NOVEL BIARYL DERIVATIVES - The invention is concerned with novel biaryl derivatives of formula , STR00001 wherein STR00002 m, R 02-19-2009
154. 20090042943 BENZOYL-PIPERIDINE DERIVATIVES AS DUAL MODULATORS OF THE 5-HT2A AND D3 RECEPTORS 02-12-2009
155. 20090042903 PIPERAZINYL-PYRIDINE DERIVATIVES - compounds of formula I STR00001 wherein R 02-12-2009
156. 20090042896 PYRROLIDINE ARYL-ETHER AS NK3 RECEPTOR ANTAGONISTS 02-12-2009
157. 20090036703 PROCESS FOR THE PRODUCTION OF ACID CHLORIDES 02-05-2009
158. 20090036452 TAAR1 LIGANDS - compound of formula STR00001 wherein R 02-05-2009
159. 20090036422 MONOAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS 02-05-2009
160. 20090036420 BENZAMIDE DERIVATIVES AND THEIR USE FOR TREATING CNS DISORDERS 02-05-2009
161. 20090030020 7H-Pyrido[3,4-D]Pyrimidin-8-Ones, Their Manufacture and Use as Protein Kinase Inhibitors 01-29-2009
162. 20090029977 DUAL MODULATORS OF 5HT2A AND D3 RECEPTORS 01-29-2009
163. 20090029976 BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES 01-29-2009
164. 20090029963 PYRAZOL DERIVATIVES - The invention is concerned with novel pyrazol derivatives of formula , STR00001 wherein STR00002 R 01-29-2009
165. 20090029962 2-AZETIDINEMETHANEAMINES AND 2-PYRROLIDINEMETHANEAMINES AS TAAR-LIGANDS 01-29-2009
166. 20090023713 HETEROCYCLIC COMPOUNDS - The invention is concerned with novel heterocyclyl compounds of formula STR00001 wherein A, X, Y, R 01-22-2009
167. 20090023709 Inhibitors of 11B-Hyrdoxysteroid Dehydrogenase 01-22-2009
168. 20090018312 IGF-1 RECEPTOR INTERACTING PROTEINS - The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and 01-15-2009
169. 20090018180 2-IMIDAZOLINES 01-15-2009
170. 20090018171 IMIDAZOLE DERIVATIVES - of formula I STR00001 wherein R 01-15-2009
171. 20090012311 PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES 01-08-2009
172. 20090012138 4-IMIDAZOLINES - compounds of formula STR00001 wherein R 01-08-2009
173. 20090012063 Novel imidazole derivatives - The invention is concerned with novel imidazole derivatives of formula , STR00001 wherein STR00002 m, E, R 01-08-2009
174. 20090005383 THYROID HORMONE ANALOGS - Provided herein are compounds of the formula : STR00001 as well as pharmaceutically acceptable salts thereof 01-01-2009
175. 20090005380 CYCLOHEXYL DERIVATIVES - compounds of formula I STR00001 wherein R 01-01-2009
176. 20090005379 Azaindole-2-Carboxamide Derivatives - compounds of formula wherein R 01-01-2009
177. 20090005370 ISOXAZOLE-IMIDAZOLE DERIVATIVES - The present invention is concerned isoxazole-imidazole derivatives having affinity and selectivity for GABA A 01-01-2009
178. 20080317714 Method of Treating Hepatitis B Viral Infection 12-25-2008
179. 20080312467 NOVEL PROCESS FOR THE PREPARATION OF 3-AMINO-PENTAN-1,5-DIOL 12-18-2008
180. 20080312288 SOLID FORMS OF 2-CHLORO-4-[1-(4-FLUORO-PHENYL)-2,5-DIMETHYL-1H-IMIDAZOL-4-YLETHYNYL]-PYRIDINE 12-18-2008
181. 20080312216 PIPERAZINE AND [1,4]DIAZEPAN DERIVATIVES AS NK ANTAGONISTS 12-18-2008
182. 20080306116 ARYLOXAZOLE, ARYLOXADIAZOLE AND BENZIMIDAZOLE DERIVATIVES 12-11-2008
183. 20080306089 PROLINAMIDE-TETRAZOLE DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS 12-11-2008
184. 20080306086 PROLINAMIDE DERIVATIVES AS NK3 ANTAGONISTS 12-11-2008
185. 20080300279 PIPERIDINE-AMIDE DERIVATIVES - The invention is concerned with novel piperidine-amide derivatives of formula wherein R 12-04-2008
186. 20080300250 ACETYLENYL-PYRAZOLO-PYRIMIDINE DERIVATIVES 12-04-2008
187. 20080293933 PROCESS FOR PREPARATION OF ENANTIOMERICALLY PURE COMPOUNDS 11-27-2008
188. 20080293787 PHARMACEUTICAL COMPOSITIONS FOR POORLY SOLUBLE DRUGS 11-27-2008
189. 20080293756 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES 11-27-2008
190. 20080293723 SPIROINDOLINONE DERIVATIVES - There are provided spiroindolinone derivatives of the formula and pharmaceutically acceptable salts and esters 11-27-2008
191. 20080287455 SULFANYL SUBSTITUTED PHENYL METHANONES - compounds of formula I whereinR 11-20-2008
192. 20080287421 3,3-SPIROINDOLINONE DERIVATIVES - There are provided compounds of the general formulas wherein X, Y, R 11-20-2008
193. 20080281103 AZASPIRO DERIVATIVES - The present invention is concerned with novel indol-3-yl-carbonyl-azaspiropiperidine derivatives as V1a receptor antagonists 11-13-2008
194. 20080280948 MODULATORS OF AMYLOID BETA - compounds of formula wherein hetaryl I, hetaryl II, and R 11-13-2008
195. 20080280924 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS 11-13-2008
196. 20080280898 Spiro-piperidine derivatives - The present invention is concerned with novel spiro-piperidine derivatives as V1a receptor antagonists 11-13-2008
197. 20080275220 METHOD FOR STABILIZING A PROTEIN - method for stabilizing an aqueous protein solution against exogenous stress and to the use of a container for 11-06-2008
198. 20080275021 PYRROLIDINE DERIVATIVES AS DUAL NK1/NK3 RECEPTOR ANTAGONISTS 11-06-2008
199. 20080269517 PROCESS FOR THE PREPARATION OF ACID HALIDES 10-30-2008
200. 20080269290 Indoles - The present invention is concerned with novel indol-2-yl-carbonyl-piperidin-benzoimidazolon and indol-2-yl-carbonyl-piperidin-benzoxazolon 10-30-2008
201. 20080269256 PYRIDINE-2-CARBOXYAMIDE DERIVATIVES - compounds of formula I: wherein R 10-30-2008
202. 20080261957 DIHYDRO-BENZO[B][1,4]DIAZEPIN-2-ONE SULFONAMIDE DERIVATIVES 10-23-2008
203. 20080261924 METHOD FOR THE TREATMENT OF BONE DISORDERS 10-23-2008
204. 20080261920 2-Aminooxazolines as TAAR1 ligands - compounds of formula I whereinX, Y, R 10-23-2008
205. 20080260827 RISEDRONATE COMPOSITIONS AND THEIR METHODS OF USE 10-23-2008
206. 20080255386 PROCESS FOR PREPARING IBANDRONATE - novel multi step synthesis of 3-amino-1-hydroxypropane-1 1-diphosphonic acid 10-16-2008
207. 20080255198 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATOR 10-16-2008
208. 20080255119 DIPHENYL-DIHYDRO-IMIDAZOPYRIDINONES - and the pharmaceutically acceptable salts and esters thereof X, R 10-16-2008
209. 20080249180 MALONAMIDES AS OREXIN ANTAGONISTS - compounds of formula I wherein Ar 10-09-2008
210. 20080249125 HETEROCYCLIC DERIVATIVES AS OREXIN ANTAGONISTS 10-09-2008
211. 20080249101 BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES 10-09-2008
212. 20080249069 METHOD OF TREATMENT USING BISPHOSPHONIC ACID 10-09-2008
213. 20080248537 BIOCATALYTIC ASYMMETRIC REDUCTION IN PREPARATION OF (S)-N-[5-(1,2-DIHYDROXY-ETHYL)-PYRAZINYL]-2,2-DIMETHYL-PROPIONAMIDE 10-09-2008
214. 20080248510 HUMAN Fc GAMMA RECEPTOR III - the field of human immunoglobulin receptors specifically the glycostructure of a human Fc gamma receptor IIIa 10-09-2008
215. 20080248468 Method for Improved Selection of Rnai Transfectants 10-09-2008
216. 20080242677 IMIDAZOLIDINONE DERIVATIVES - The invention is concerned with novel imidazolidinone derivatives of formula : wherein R 10-02-2008
217. 20080234356 2-PHENYL-3,3,3-TRIFLUORO-2-HYDROXY-PROPIONIC ACID DERIVATIVES 09-25-2008
218. 20080234290 NEW INDOLE OR BENZIMIDAZOLE DERIVATIVES AS CB1 INVERSE AGONISTS 09-25-2008
219. 20080234277 NOVEL AZA-PYRIDOPYRIMIDINONE DERIVATIVES 09-25-2008
220. 20080234255 SUBSTITUTED PYRIMIDODIAZEPINES - PLK1 inhibitor compounds of formula I: Useful in the treatment or control of cell proliferative disorders 09-25-2008
221. 20080226635 Antibodies against insulin-like growth factor I receptor and uses thereof 09-18-2008
222. 20080221327 SYNTHESIS OF GLYT-1 INHIBITORS - process for preparation of a compound of formula I wherein Het, R 09-11-2008
223. 20080221166 AMINOAMIDES AS OREXIN ANTAGONISTS - compounds of formula I wherein Ar 09-11-2008
224. 20080214826 PROCESSES FOR THE MANUFACTURE OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE 09-04-2008
225. 20080214561 SOLID FORMS OF [4-(3-FLUORO-5-TRIFLUOROMETHYL-PYRIDIN-2-YL)-PIPERAZIN-1-YL-[5-METHANESULFONYL-2-((S)-2,2,2-TRIFLUORO-1-METHYL-ETHOXY)-PHENYL]-METHANONE 09-04-2008
226. 20080214505 Risedronate compositions and their methods of use 09-04-2008
227. 20080207563 METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELLS 08-28-2008